Genocea Biosciences reported $-15978000 in Pre-Tax Profit for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agenus AGEN:US $ -50.6M 17M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Cytokinetics CYTK:US $ -19.82M 66.93M
Cytori Therapeutics CYTX:US $ -5.28M 1.17M
Genocea Biosciences GNCA:US $ -15.98M 2.7M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Mirati Therapeutics MRTX:US $ -176.44M 11.94M
Novavax NVAX:US $ 206.07M 1035.74M
Prothena PRTA:US $ -37.96M 4.86M